Trinity Biotech and Perceptive Credit sign fifth credit amendment waiving minimum cash covenant breaches

Trinity Biotech and its U.S. subsidiaries entered a Limited Waiver and Fifth Amendment to their credit agreement with Perceptive Credit Holdings III, LP as administrative agent, dated November 6, 2026. Lenders waived the minimum liquidity covenant for June through October 2026, after the company reported shortfalls for June, July and August. The amendment also restates the roughly $96.2 million note, and the liens securing the debt remain in place.

12 Nov 2026 · Trinity Biotech Plc TRIB · Company news

Company's press release (SEC filing): Trinity Biotech Plc ↗

Written by CompePharma's editorial system from the company's filing; claims are the company's. AI-assisted; check the source before acting. Not investment advice.

More FinancingAll →

Financing

Trinity Biotech and Perceptive Credit sign fifth credit amendment waiving minimum cash covenant breaches

IM Cannabis reports C$13.9M nine-month net loss as revenue slides to C$9.0M

Femasys Q3 2026: $30M private placement closed; U.S. sales flat, total sales fall 44.5% to $404,597

Mingteng International, an automotive mold maker, prices $2.00/share registered direct offering with pre-funded warrants

Organigram to acquire Aurora Cannabis for about C$561M, backed by BAT private placement and ATB credit facilities

Windward Bio prices Nasdaq IPO of 10.3 million shares at $17, targeting $225 million in gross proceeds

Lichen International prices $3.5M registered direct offering of units with warrants on Nasdaq